House of Commons Hansard #69 of the 41st Parliament, 1st Session. (The original version is on Parliament's site.) The word of the day was plan.

Topics

Question No. 217
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

NDP

Fin Donnelly New Westminster—Coquitlam, BC

With respect to budget cuts at the Department of Fisheries and Oceans (DFO): (a) which specific directorates and programs are affected and what was the process followed to determine whether or not to make cuts to a specific directorate and program; (b) what, if any, DFO scientists were consulted regarding the considered cuts; (c) what scientists outside of DFO were consulted; (d) for each directorate and program specified in (a), what is the number of current full-time, part-time and contract scientific positions; (e) for each directorate and program specified in (a), what is the number of full-time, part-time and contract scientists who have been given “workforce adjustment” letters; (f) for each directorate and program specified in (a), what is the number of full-time, part-time and contract scientists who are going to be moved out of their current “job functions”; (g) what are all programs run by a single scientist who has been given a “workforce adjustment” letter, and, for each program identified, what, if any, steps have been taken to make sure that the program continues; (h) what process will be followed to place scientists in appropriate research areas; and (i) has the government taken steps to limit the effects of the cuts on scientists whose high level of specialization in a particular field may make finding an appropriate replacement position impossible?

(Return tabled)

Question No. 218
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

Liberal

John McKay Scarborough—Guildwood, ON

With respect to Canada’s fleet of submarines, which is comprised of HMCS Victoria, HMCS Windsor, HMCS Chicoutimi, and HMCS Corner Brook: (a) what is the total cost, broken down by vessel, and itemized by categories including maintenance, repairs, staffing, and all others relevant categories for (i) the most recent fiscal year, (ii) since their acquisition; (b) what is the estimated cost that the government anticipates to spend before the fleet is active again, broken down by vessel; (c) what are the dates that the government anticipates each vessel will return to service; and (d) which companies have been contracted to perform work on the vessels in order to return the fleet to operation?

(Return tabled)

Question No. 220
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

NDP

Don Davies Vancouver Kingsway, BC

With respect to Temporary Resident Visas (TRVs): (a) how many individuals per year, over the last ten years, who were issued a TRV have gone on to make a refugee claim; (b) over the last ten years, (i) what have been the ten most common countries of origin of the refugee claimants in (a), (ii) how many refugee claimants have come from each of the ten countries per year; (c) of the refugee claimants mentioned in (a), what is the breakdown in terms of (i) gender, (ii) age; (d) what is the total number of TRVs issued per year over the last ten years; and (e) does the Department of Citizenship and Immigration know how many TRV holders have stayed in Canada beyond the expiry date of their visas in the last ten years and, if so, how many have done so?

(Return tabled)

Question No. 222
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

NDP

Don Davies Vancouver Kingsway, BC

With respect to five-year multiple-entry visas: (a) how many visas of this type have been issued in total per year over the last ten years; (b) what is the breakdown in terms of (i) gender, (ii) age; (c) how many have been issued per year to individuals who have a pending application for permanent residence, and what is the breakdown in terms of permanent residency class applied for; and (d) over the last ten years, (i) what have been the ten most common countries of origin for individuals who have received multiple-entry visas, (ii) how many applicants have come from each of the ten countries per year?

(Return tabled)

Question No. 223
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

Liberal

Kirsty Duncan Etobicoke North, ON

With respect to Lyme disease-carrying ticks and Lyme disease in Canada: (a) what percentage of Lyme disease cases are thought to be reported, (i) what percentage of people who receive treatment for Lyme disease develop post-treatment Lyme disease syndrome, (ii) what percentage of people with untreated Lyme disease infections experience intermittent bouts of arthritis, (iii) what percentage of untreated Lyme disease patients are at risk of developing chronic neurological complaints months to years after infection; (b) based on all epidemiological data collected since Lyme disease became a nationally-reportable disease, what is the most recent data available about Lyme disease cases, broken down (i) by province, (ii) by month, (iii) by symptom, (iv) incidence by age and sex; (c) how does the government define a “Lyme-endemic area”, (i) in what specific areas of Canada are ticks endemic and highly endemic, (ii) what areas of Canada have the highest numbers of human infections; (d) what is Lyme disease’s (i) ranking among vector-borne diseases in Canada, (ii) ranking among nationally notifiable diseases; (e) is it possible to have more than one tick-borne infection, and, if so, (i) are possible co-infections being investigated and tracked, (ii) does one’s chance of having multiple tick-borne infections depend on geographic location, and, if so, what areas are particularly at risk, (iii) what is the rate of co-infection by province; (f) broken down by province, over the last 20 years, how has a warming climate impacted Lyme disease, in particular, (i) how has warming impacted tick distribution by province, (ii) how has warming impacted the distribution of Lyme disease by province; (g) what does the government project will be the effect of climate change on (i) the geographical range of ticks in 2020 and 2050, (ii) the distribution of ticks across Canada, (iii) human Lyme disease infections, (iv) the distribution of Lyme disease infections in Canada; (h) how has municipal development changed in tick-endemic areas throughout Canada over the last 20 years, (i) how have these changes brought humans in contact with ticks, (ii) how has development impacted the distribution of the disease, (iii) what are the government’s projections concerning how development will change over the next 40 years, (iv) what are the government’s projections concerning how development will impact the spread of Lyme disease over the next 40 years; (i) what are Health Canada’s recommended treatment guidelines for Lyme disease, and what was the process used to develop them; (j) what tests does Health Canada recommend for diagnosing cases of Lyme disease, (i) what is the percentage accuracy of the recommended tests at each stage of disease, namely, when a patient has an erythema migrans rash, when a patient is in the early disseminated stage (days to weeks post-tick bite), and when a person is in the late disseminated stage (months to years post-tick bite), (ii) what tests for diagnosing Lyme disease are available and recommended in Canada during each of the above-mentioned stages of the disease, (iii) can patients be treated based solely on their symptoms or must they have had positive test results; (k) is the government aware of any organization that recommends physicians who are familiar with diagnosing and treating Lyme disease, and, if so, where can this information be accessed; (l) what percentage of patients with Lyme disease respond well to antibiotics, (i) what percentage of patients with Lyme disease experience fatigue, muscle aches, sleep disturbance, or difficulty thinking even after completing a recommended course of antibiotic treatment, (ii) what research has been undertaken regarding the benefits and risks of a longer course of antibiotics, (iii) what are Health Canada’s recommendations concerning a longer course of antibiotics, (iv) what follow-up has Health Canada undertaken to ensure that patients have access to a longer course of antibiotic treatment if required; (m) what, if any, recommendations does Health Canada make concerning those who suffer post-treatment Lyme disease syndrome; (n) what, if any, resources does Health Canada provide to clinicians regarding diagnosis, treatment, and testing; (o) what, if any, resources does Health Canada provide to clinicians for continuing medical education on the topic of Lyme disease; (p) what, if any, case definition and report forms does Health Canada make available concerning Lyme disease, and when were each of these forms last updated by Health Canada; (q) what specific actions are Health Canada and the Canadian Institutes of Health Research undertaking regarding prevention of Lyme disease, including, but not limited to, (i) programs of research, (ii) programs of service, (iii) education programs for the public and healthcare providers; (r) what resources have been provided to each initiative identified in response to (q); (s) what, if anything, is Health Canada doing with national surveillance data regarding Lyme disease, in particular, (i) what is it doing to maintain such data, (ii) what is it doing to analyze such data, (iii) what resources has it allocated to such activities; (t) in what, if any, epidemiologic investigations is the government currently involved, in any capacity, including that of funding, (i) what resources is the government providing for any such study; (u) what, if any, diagnostic and reference laboratory services does the government provide in relation to Lyme disease, (i) what financial resources are provided for any such services; (v) what, if any, steps is Health Canada and the Canadian Institute for Health Research taking to develop and test strategies for the control and prevention of Lyme disease in humans; and (w) what, if any, information does Health Canada provide to pregnant mothers about Lyme disease?

(Return tabled)

Question No. 224
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

Liberal

Kirsty Duncan Etobicoke North, ON

With respect to development of the oil sands, and its impacts on Aboriginal communities: (a) what are all the studies, along with their dates and results, undertaken by the government concerning the (i) possible impacts of the oil sands industry on land, water, and wildlife, (ii) potential impacts on Aboriginal livelihoods, inherent and treaty rights, and constitutional rights; (b) which government accommodation and consultation policies regarding the oil sands have been designed in partnership with Aboriginal peoples to ensure that free, prior and informed consent is obtained, and how does the government ensure that consultation policies are (i) designed in partnership with Aboriginal peoples, (ii) consistent with the United Nations Declaration on the Rights of Indigenous Peoples; (c) what are all consultations, including the dates of the consultations and those present, undertaken by the government with Aboriginal peoples, where there was consideration given to oil sands-related activities that might impact Section 35 rights, and what were the results or conclusions of these consultations; (d) does the government ensure that consultation with Aboriginal peoples occurs early in the decision-making process as related to the development of the oil sands and, if so, how does it do this; (e) what are all consultations with Aboriginal peoples which occurred early in the decision-making process as related to the development of the oil sands, and for each such consultation, how does it meet the government’s criteria for “early consultation”; (f) what are all legal challenges that have been undertaken or are being undertaken by First Nations communities against the government as related to the oil sands, and what is the stated reason for each challenge; (g) what are the studies, along with their dates and results, undertaken by the government concerning the possible impacts of legal challenges by First Nations communities on the oil sands industry; (h) which, if any, First Nations communities have asked for a full public inquiry into the impact of oil sands development and what are (i) the reasons provided for each such request, (ii) the projected cost of such an inquiry, (iii) the steps taken by the government to address each identified concern as outlined in (h)(i); (i) does the federal government plan to ensure that development in the oil sands region is consistent with the constitutionally-protected rights of Aboriginal peoples and the internationally-accepted doctrine of free, prior, and informed consent, and (i) other than actions referenced in the responses to parts (a) through (h), what federal decisions have been taken and what federal policies or programs have been developed taking into account Aboriginal peoples’ constitutionally-protected rights; and (j) what, if any, studies has the government funded to ensure that Aboriginal communities impacted or potentially impacted by the oil sands have the resources to direct their own baseline health studies and environmental monitoring programs?

(Return tabled)

Question No. 225
Questions Passed as Orders for Returns
Routine Proceedings

3:20 p.m.

NDP

Manon Perreault Montcalm, QC

With respect to the Enabling Accessibility Fund: (a) how many applications were successful and received funding under this program, and how many applications were rejected through calls for proposals, since the start of the program; (b) with respect to successful applications, what was the location and value of each project, broken down by province and federal electoral district, through calls for proposals since the start of the program; (c) what is the total cost of administering the program thus far for each year since the start of the program; (d) how much funding is left; (e) how many major projects under this program will go to or went to expanding existing centres; (f) what is the value of the successful major projects applications that went to (i) the construction of new centres, (ii) the expanding of existing centres; (g) how many of the successful Mid-Sized Projects Enabling Accessibility Fund applications went to (i) renovating buildings, (ii) modifying vehicles, (iii) making information and communications more accessible; (h) what is the value of the successful Small Projects Enabling Accessibility Fund applications that went to (i) renovating buildings, (ii) modifying vehicles, (iii) making information and communications more accessible; (i) what is the reason most often given for rejecting an application; (j) what are the reasons given for rejecting an application and what is the frequency of each reason; (k) will the program be renewed next year; and (l) when will the next call for proposals be issued?

(Return tabled)

Question No. 226
Questions Passed as Orders for Returns
Routine Proceedings

January 30th, 2012 / 3:20 p.m.

Liberal

Mark Eyking Sydney—Victoria, NS

With regard to the Canadian International Development Agency’s spending on the delivery of vaccines and immunizations through Canada's official development assistance: (a) what are Canada’s current and future financial commitments on vaccines and immunizations from all branches, projects and programs within CIDA, including bilateral, multilateral, and geographic/partnership branch, broken down by individual commitment; (b) what specific current or future immunizations or vaccines programs or projects, broken down by recipient country and CIDA stream of funding with associated funding amounts, are related to the roll-out of the Muskoka Initiative; and (c) when has the monitoring and evaluation of Canada’s immunizations and vaccines programs as promised by the Prime Minister during the 2010 Muskoka G8 taken place or when will it take place and will it be under the auspices of the United Nations Commission on Information and Accountability for Women’s and Children’s Health?